EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

医学 核医学

  • 影响指数:10.047
  • 中科院分区:医学 1区[Top] 医学 1 区
  • 审稿周期:平均1.75月
  • 自引率:15.3%
  • 录取率:43.75%
  • ISSN:2190-572X
  • 发刊频率:暂无数据
  • 年文章数:454
  • 国人占比:5.95%
  • 期刊网址:点击查看
  • 研究方向:核医学;肿
  • 期刊攻略
  • IF变化趋势
  • 期刊占比
  • 最新文章

期刊简介

3 BIOTECH杂志暂不明确行业,暂不明确子行业的级别不明杂志

收稿要求

暂无数据

建议

杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.

DOI:10.1007/s00259-022-05882-x

发表时间:2022 Jun 29

作者:Gafita A;Rauscher I;Fendler WP;Murthy V;Hui W;Armstrong WR;Herrmann K;Weber WA;Calais J;Eiber M;Weber M;Benz MR

Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy.

DOI:10.1007/s00259-022-05883-w

发表时间:2022 Jun 30

作者:Xue S;Gafita A;Dong C;Zhao Y;Tetteh G;Menze BH;Ziegler S;Weber W;Afshar-Oromieh A;Rominger A;Eiber M;Shi K

A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death.

DOI:10.1007/s00259-022-05880-z

发表时间:2022 Jul 2

作者:Ho Shon I;Hennessy T;Guille J;Gotsbacher MP;Lay AJ;McBride B;Codd R;Hogg PJ

Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study.

DOI:10.1007/s00259-022-05865-y

发表时间:2022 Jul 4

作者:Lin YS;Yang H;Li XY;Wu LQ;Xu JG;Yang AM;Gao ZR;Ding Y;Zhang YQ;Chen K;Mu ZZ;Jia JM;Niu N;Sun D;Zhang X;Zhang SQ;Geng QQ;Zhang YJ;Chen FN;He BX

Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens.

DOI:10.1007/s00259-022-05894-7

发表时间:2022 Jul 4

作者:Cen P;Zhou Y;Cui C;Wei Y;Cheng Z;Wu S;Zhang H;Tian M

公众号